Skip to main content

Table 1 Demographic and clinical characteristics of the participants

From: Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Age at intervention (years)

43

37

43

45

37

Sex

Male

Male

Male

Male

Male

Race

White

White

White

White

Black

Exposure

Stone carver

Sandblaster

Stone quarry truck driver

Sandblaster

Sandblaster

Duration of symptoms (years)

13

5

3

11

10

Main symptom

Dyspnea on exertion

Progressive dyspnea

Dyspnea on exertion

Dyspnea on exertion

Dyspnea on exertion

Other lung diseases

No

Tuberculosis in 2004

Tuberculosis in 1999

Pneumonia in 2005

Tuberculosis in 2002

Smoking

No

0.6 pack-years, stopped in 2004

8 pack-years, stopped in 1999

No

No

Post-BD FEV1 (%)

55.7

48.3

62.1

64.6

62.9

Post-BD FVC (%)

89.3

61.9

94.7

100.1

93.7

Main CT findings at admission

Irregular opacities, mainly at the UULL, with traction bronchiectasis

Diffuse reticulo-nodular infiltrate

Disseminated small nodules, traction bronchiectasis

Disseminated small nodules, traction bronchiectasis

Disseminated small nodules, traction bronchiectasis

Date of infusion

8 Aug 2009

27 Aug 2009

3 Sep 2009

26 Oct 2012

4 Feb 2010

Last outpatient visit and status

3 Mar 2015, stable

3 Dec 2014, stable

3 Dec 2012, stable

22 Nov 2014, stable

22 Aug 2011, active TBa

  1. BD Bronchodilator, FEV 1 Forced expiratory volume in 1 s, FCV Forced vital capacity, CT Computed tomography, UULL Upper lobes, TB Tuberculosis
  2. amoved to another state